---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-029309"
form_type: "8-K"
ticker: "BDX"
cik: "0000010795"
company_name: "BECTON DICKINSON & CO"
filed_at: "2024-06-07T23:59:59+00:00"
generated_at: "2026-06-01T05:27:56.724701+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# BD issues €1.8B + $600M notes to fund Edwards Critical Care acquisition

## Summary
- €1.0B 3.828% notes due 2032, €800M 4.029% notes due 2036, $600M 5.081% notes due 2029 issued June 7.
- Net proceeds, with commercial paper and cash, to fund cash consideration for Edwards Lifesciences Critical Care buy.
- If acquisition not closed by June 3, 2025, notes subject to special mandatory redemption at 101% of par.
- Proceeds not escrowed; issuances not conditioned on deal completion.
- BD fully guarantees Becton Finance €800M notes; all notes are senior unsecured.

## SEC filing metadata
- accession: 0001140361-24-029309
- form_type: 8-K
- ticker: BDX
- cik: 0000010795
- company_name: BECTON DICKINSON & CO
- filed_at: 2024-06-07T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/10795/000114036124029309/0001140361-24-029309-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/10795/000114036124029309/ny20030306x14_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-029309
- JSON: https://secwatch.observer/filing/0001140361-24-029309.json
- Plain text: https://secwatch.observer/filing/0001140361-24-029309.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.